LSV ASSET MANAGEMENT - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,446
-18.9%
408,7580.0%0.02%
-16.7%
Q2 2023$7,946
+14.9%
408,758
+67.7%
0.02%
+12.5%
Q1 2023$6,915
+56.2%
243,736
+61.0%
0.02%
+60.0%
Q4 2022$4,426
-97.1%
151,418
+4503.8%
0.01%
Q4 2020$153,000
-73.9%
3,289
-76.2%
0.00%
-100.0%
Q3 2020$586,000
-92.8%
13,800
-91.8%
0.00%
-94.1%
Q2 2020$8,084,000
-45.1%
168,501
-47.4%
0.02%
-52.8%
Q1 2020$14,730,000
-33.6%
320,227
-13.3%
0.04%
+2.9%
Q4 2019$22,180,000
-15.1%
369,177
-20.0%
0.04%
-18.6%
Q3 2019$26,110,000
+16.0%
461,558
+14.1%
0.04%
+19.4%
Q2 2019$22,515,000
+78.4%
404,369
+61.7%
0.04%
+80.0%
Q1 2019$12,622,000
+276.2%
250,004
+200.2%
0.02%
+233.3%
Q4 2018$3,355,000
-45.8%
83,289
-6.8%
0.01%
-33.3%
Q3 2018$6,194,000
-86.2%
89,341
-84.9%
0.01%
-87.1%
Q2 2018$44,839,000
-0.9%
592,642
-31.0%
0.07%
-2.8%
Q1 2018$45,268,000
+15.5%
859,142
+17.1%
0.07%
+16.1%
Q4 2017$39,200,000
+188.6%
733,822
+222.1%
0.06%
+181.8%
Q3 2017$13,585,000227,7940.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders